These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2688781)

  • 1. Comments on the Northwick Park 'Functional' Psychosis Study.
    Goodwin GM; Johnson DA; McCreadie RG
    Br J Psychiatry; 1989 Mar; 154():406-9. PubMed ID: 2688781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Northwick Park "functional" psychosis study: diagnosis and treatment response.
    Johnstone EC; Crow TJ; Frith CD; Owens DG
    Lancet; 1988 Jul; 2(8603):119-25. PubMed ID: 2899186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood-incongruent versus mood-congruent psychosis: differential antipsychotic response to lithium therapy.
    Zemlan FP; Hirschowitz J; Garver DL
    Psychiatry Res; 1984 Apr; 11(4):317-28. PubMed ID: 6588396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosis, lithium-induced antipsychotic response, and seasonality.
    Garver DL; Hutchinson LJ
    Psychiatry Res; 1988 Dec; 26(3):279-86. PubMed ID: 3146760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family study of lithium-responsive psychosis.
    Sautter FJ; McDermott BE; Garver DL
    J Affect Disord; 1990 Sep; 20(1):63-9. PubMed ID: 2147191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Northwick Park 'Functional' Psychosis Study: diagnosis and outcome.
    Johnstone EC; Frith CD; Crow TJ; Owens DG; Done DJ; Baldwin EJ; Charlette A
    Psychol Med; 1992 May; 22(2):331-46. PubMed ID: 1352049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatment.
    Johnstone EC; Crow TJ; Owens DG; Frith CD
    J Psychopharmacol; 1991 Jan; 5(4):388-95. PubMed ID: 22282848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium and chlorpromazine in psychotic inpatients.
    Braden W; Fink EB; Qualls CB; Ho CK; Samuels WO
    Psychiatry Res; 1982 Aug; 7(1):69-81. PubMed ID: 6813888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
    Remington GJ; Voineskos G; Pollock B; Reed K; Coulter K
    Am J Psychiatry; 1990 Sep; 147(9):1231-3. PubMed ID: 1974747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia.
    van Kammen DP; Docherty JP; Marder SR; Rayner JN; Bunney WE
    Arch Gen Psychiatry; 1982 Mar; 39(3):275-81. PubMed ID: 6802100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to lithium in patients with psychoses.
    Schexnayder LW; Hirschowitz J; Sautter FJ; Garver DL
    Am J Psychiatry; 1995 Oct; 152(10):1511-3. PubMed ID: 7573592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of schizoaffective disorders.
    Goodnick PJ; Meltzer HY
    Schizophr Bull; 1984; 10(1):30-48. PubMed ID: 6142525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research.
    Pope HG; Lipinski JF
    Arch Gen Psychiatry; 1978 Jul; 35(7):811-28. PubMed ID: 354552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.
    van Kammen DP; Docherty JP; Bunney WE
    Biol Psychiatry; 1982 Feb; 17(2):233-42. PubMed ID: 7074181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response.
    van Kammen DP; Docherty JP; Marder SR; Schulz SC; Dalton L; Bunney WE
    Arch Gen Psychiatry; 1982 Mar; 39(3):261-6. PubMed ID: 7065839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.